Clinical Trial

The Effect of Consumed Berries on Extracellular Vesicle Signalling in the Body

Study acronym: NutriEV RCT
Recruiting
View on ClinicalTrials.gov →
Summary
This study examines how berry consumption influences the signaling and distribution of extracellular vesicles (EVs) in the human body. EVs are small bilipid-layered nanoparticles released by cells. EVs carry proteins, lipids, and genetic material, and play a key role in cell-to-cell communication. The composition of EVs reflects the state of their cells of origin, and EVs can affect other cells by delivering their biological contents. EVs offer significant potential for both diagnostics and new therapies. Recent research has shown that EVs can be found in blood, urine, sweat, and can even cross biological barriers such as the blood-brain barrier and placenta. Many living organisms, including mammalian cells, bacteria, and plants, release EVs. Berries such as cloudberries and lingonberries have demonstrated positive effects on gut microbiota and metabolism, supporting digestive and metabolic health. In this study, a nutritional intervention will be conducted to investigate the effects of berry consumption on extracellular vesicle signaling of human cells and the gut microbiota, as well as the biodistribution of berry-derived vesicles in the human body.
Protocol Amendment History 2 changes
notable Primary completion pushed: 2026-05-31 -> 2026-08-31 2026-06-10
minor Completion pushed: 2026-08-30 -> 2026-12-31 2026-06-10
Trial Details
NCT Number NCT07381933
Lead Sponsor University of Oulu
Collaborators: European Innovation Council
Conditions Healthy, Extracellular Vesicles
Enrollment 60 participants
Start Date 2026-01-23
Primary Completion 2026-08-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-06-09